EUVIMEDEUVIMED entdecken
Crossref

Combined Compression and Cooling Therapy for Taxane Chemotherapy-induced Peripheral Neuropathy in Lung Cancer

Yasuhiro Nakajima, Kozo Kuribayashi, Akio Tada, Akichika Nagano, Toshiyuki Minami, Arihiko Kanehiro, Takashi Kijima

Anticancer Research · 2025

DOI: 10.21873/anticanres.17786 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Yasuhiro Nakajima und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respiratory Medicine, Department of Internal Medicine, Society of St. Franciscan Himeji St. Mary's Hospital, Himeji, Japan. Hauptthemen laut MEDLINE: Lung Neoplasms, Peripheral Nervous System Diseases, Taxoids, Antineoplastic Combined Chemotherapy Protocols.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Chemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating side-effect of taxane-based treatments. This study aimed to assess the efficacy and safety of a combined compression and cooling therapy for CIPN prevention in patients with lung cancer receiving taxane-containing regimens. PATIENTS AND METHODS: We retrospectively analyzed 53 patients with advanced lung cancer treated with taxane-based chemotherapy between April 2021 and March 2023. Patients underwent compression therapy using surgical gloves and elastic stockings, combined with cooling gloves and foot ice pillows, during chemotherapy infusion. RESULTS: CIPN incidence was 20.8%, with no cases of grade ≥3 neuropathy. Paclitaxel and nab-paclitaxel showed lower CIPN rates (19.0% and 15.0%, respectively) compared to docetaxel (33.3%). No patients required chemotherapy dose reductions, and adverse events related to the therapy were mild and reversible. CONCLUSION: Combined compression and cooling therapy appears to be a safe, feasible, and non-pharmacologic strategy for reducing CIPN in taxane-treated lung cancer patients. Further prospective validation is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsPeripheral Nervous System DiseasesTaxoidsAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleMaleMiddle AgedAgedRetrospective StudiesPaclitaxelDocetaxelAdultBridged-Ring CompoundsAlbumins

Stichwörter der Autor:innen

Chemotherapy-induced peripheral neuropathy (CIPN)compression therapycooling therapytaxanes-based chemotherapy

Substanzen

TaxoidsPaclitaxelDocetaxeltaxane130-nm albumin-bound paclitaxelBridged-Ring CompoundsAlbumins

Autor:innen und Institutionen

  • Division of Respiratory Medicine, Department of Internal Medicine, Society of St. Franciscan Himeji St. Mary's Hospital, Himeji, Japan.
  • Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Japan.
  • Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Japan kuririn@hyo-med.ac.jp.

Zitieren

APA

Nakajima, Y., Kuribayashi, K., Tada, A., Nagano, A., Minami, T., Kanehiro, A., & Kijima, T. (2025). Combined Compression and Cooling Therapy for Taxane Chemotherapy-induced Peripheral Neuropathy in Lung Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17786

Vancouver

Nakajima Y, Kuribayashi K, Tada A, Nagano A, Minami T, Kanehiro A, et al. Combined Compression and Cooling Therapy for Taxane Chemotherapy-induced Peripheral Neuropathy in Lung Cancer. Anticancer Research. 2025. doi:10.21873/anticanres.17786

BibTeX
@article{Nakajima2025,
  author = {Nakajima, Yasuhiro and Kuribayashi, Kozo and Tada, Akio and Nagano, Akichika and Minami, Toshiyuki and Kanehiro, Arihiko and Kijima, Takashi},
  title = {Combined Compression and Cooling Therapy for Taxane Chemotherapy-induced Peripheral Neuropathy in Lung Cancer},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17786}
}
Kostenlos starten →